Outcomes of 3-weekly doxorubicin and cyclophosphamide followed by paclitaxel (AC/T) in a randomized trial (RCT) compared to a case-control matched British Columbia (BC) breast cancer population.
Sheridan Marie Wilson
No relevant relationships to disclose
Yvonne Zheng
No relevant relationships to disclose
Judy-Anne W. Chapman
No relevant relationships to disclose
Margot J. Burnell
No relevant relationships to disclose
Caroline Speers
No relevant relationships to disclose
Emily Baxter
No relevant relationships to disclose
Scott Tyldesley
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Karen A. Gelmon
No relevant relationships to disclose
Caroline A. Lohrisch
No relevant relationships to disclose